Jenna L. Riis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jenna L. Riis has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Douglas A. Granger
Institute for Interdisciplinary Salivary Bioscience Research, University of California, Irvine, Irvine, CA, United States
5 shared publicationsCrystal I. Bryce
T. Denny Sanford School of Social & Family Dynamics, Arizona State University, Tempe, AZ, USA
3 shared publicationsHedyeh Ahmadi
Institute for Interdisciplinary Salivary Bioscience Research, University of California, Irvine, CA, USA
3 shared publicationsKatrina R. Hamilton
Institute for Interdisciplinary Salivary Bioscience Research, University of California, Irvine, CA, USA
3 shared publicationsClancy Blair
Department of Population Health and Department of Applied Psychology, New York University, New York, NY, USA
2 shared publications- Olga Kornienko
Department of Psychology, George Mason University, Fairfax, USA
2 shared publications
Latest Publications
- Open Access
- 18 March 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 813564
Characterizing and Evaluating Diurnal Salivary Uric Acid Across Pregnancy Among Healthy Women
Uric acid levels during pregnancy have been examined as a potential indicator of risk for gestational diabetes mellites, hypertension, and related adverse birth outcomes. However, evidence supporting the utility of serum uric acid levels in predicting poor maternal and fetal health has been mixed. The lack of consistent findings may be due to limitations inherent in serum-based biomeasure evaluations, such as minimal repeated assessments and variability in the timing of these assessments. To address these gaps, we examined repeated measurements of diurnal salivary uric acid (sUA) levels in a sample of 44 healthy women across early-mid and late pregnancy. We assessed potential covariates and confounds of sUA levels and diurnal trajectories, as well as associations between maternal weight gain and blood pressure during pregnancy and sUA concentrations. Using multilevel linear models, we found sUA increased across pregnancy and displayed a robust diurnal pattern with the highest concentrations at waking, a steep decline in the early morning, and decreasing levels across the day. Maternal pre-pregnancy BMI, age, prior-night sleep duration, and fetal sex were associated with sUA levels and/or diurnal slopes. Maternal blood pressure and gestational weight gain also showed significant associations with sUA levels across pregnancy. Our results expand upon those found with serum UA measurements. Further, they demonstrate the feasibility of using at-home, minimally-invasive saliva sampling procedures to track UA levels across pregnancy with potential applications for the long-term monitoring of maternal cardiometabolic risk.
- 18 March 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 813564
Open AccessCharacterizing and Evaluating Diurnal Salivary Uric Acid Across Pregnancy Among Healthy Women
Uric acid levels during pregnancy have been examined as a potential indicator of risk for gestational diabetes mellites, hypertension, and related adverse birth outcomes. However, evidence supporting the utility of serum uric acid levels in predicting poor maternal and fetal health has been mixed. The lack of consistent findings may be due to limitations inherent in serum-based biomeasure evaluations, such as minimal repeated assessments and variability in the timing of these assessments. To address these gaps, we examined repeated measurements of diurnal salivary uric acid (sUA) levels in a sample of 44 healthy women across early-mid and late pregnancy. We assessed potential covariates and confounds of sUA levels and diurnal trajectories, as well as associations between maternal weight gain and blood pressure during pregnancy and sUA concentrations. Using multilevel linear models, we found sUA increased across pregnancy and displayed a robust diurnal pattern with the highest concentrations at waking, a steep decline in the early morning, and decreasing levels across the day. Maternal pre-pregnancy BMI, age, prior-night sleep duration, and fetal sex were associated with sUA levels and/or diurnal slopes. Maternal blood pressure and gestational weight gain also showed significant associations with sUA levels across pregnancy. Our results expand upon those found with serum UA measurements. Further, they demonstrate the feasibility of using at-home, minimally-invasive saliva sampling procedures to track UA levels across pregnancy with potential applications for the long-term monitoring of maternal cardiometabolic risk.
- 16 February 2022
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 139, 105690
Preliminary insights into associations between C-reactive protein and social network dynamics
- 16 February 2022
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 139, 105690
Preliminary insights into associations between C-reactive protein and social network dynamics
- Open Access
- 1 July 2021
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 129, 105274
Censored data considerations and analytical approaches for salivary bioscience data
- 1 July 2021
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 129, 105274
Open AccessCensored data considerations and analytical approaches for salivary bioscience data
- 12 September 2020
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 91, 105-116
Best practice recommendations for the measurement and interpretation of salivary proinflammatory cytokines in biobehavioral research
- 12 September 2020
- Published by Elsevier in Brain, Behavior, and Immunity
- Vol. 91, 105-116
Best practice recommendations for the measurement and interpretation of salivary proinflammatory cytokines in biobehavioral research
- Open Access
- 28 August 2020
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Correspondence Between Cytomegalovirus Immunoglobulin-G Levels Measured in Saliva and Serum
Human cytomegalovirus (HCMV) infects more than 80% of the global population. While mostly asymptomatic, HCMV infection can be serious among the immunocompromised, and it is implicated in chronic disease pathophysiology in adulthood. Large-scale minimally invasive HCMV screening could advance research and public health efforts to monitor infection prevalence and prevent or mitigate downstream risks associated with infection. We examine the utility of measuring HCMV immunoglobulin-G (IgG) levels in saliva as an index of serum levels. Matched serum and saliva samples from healthy adults (N = 98; 44% female; 51% white) were assayed for HCMV IgG, total salivary protein, and salivary markers related to oral inflammation, blood, and tissue integrity. We examine the serum-saliva association for HCMV IgG and assess the influence of participant characteristics and factors specific to the oral compartment (e.g., oral inflammation) on HCMV IgG levels and cross-specimen relations. We found a robust serum-saliva association for HCMV IgG with serum antibody levels accounting for >60% of the variance in salivary levels. This relation remained after adjusting for key demographic and oral immune-related variables. Compared to the serum test, the salivary HCMV IgG test had 51% sensitivity and 97% specificity. With improvements in assay performance and sample optimization, HCMV antibody levels in oral fluids may be a useful proxy for serum levels.
- 28 August 2020
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11
Open AccessCorrespondence Between Cytomegalovirus Immunoglobulin-G Levels Measured in Saliva and Serum
Human cytomegalovirus (HCMV) infects more than 80% of the global population. While mostly asymptomatic, HCMV infection can be serious among the immunocompromised, and it is implicated in chronic disease pathophysiology in adulthood. Large-scale minimally invasive HCMV screening could advance research and public health efforts to monitor infection prevalence and prevent or mitigate downstream risks associated with infection. We examine the utility of measuring HCMV immunoglobulin-G (IgG) levels in saliva as an index of serum levels. Matched serum and saliva samples from healthy adults (N = 98; 44% female; 51% white) were assayed for HCMV IgG, total salivary protein, and salivary markers related to oral inflammation, blood, and tissue integrity. We examine the serum-saliva association for HCMV IgG and assess the influence of participant characteristics and factors specific to the oral compartment (e.g., oral inflammation) on HCMV IgG levels and cross-specimen relations. We found a robust serum-saliva association for HCMV IgG with serum antibody levels accounting for >60% of the variance in salivary levels. This relation remained after adjusting for key demographic and oral immune-related variables. Compared to the serum test, the salivary HCMV IgG test had 51% sensitivity and 97% specificity. With improvements in assay performance and sample optimization, HCMV antibody levels in oral fluids may be a useful proxy for serum levels.
- 8 April 2020
- Published by Springer Nature
- p. 49-86
Analytical Strategies and Tactics in Salivary Bioscience
- 8 April 2020
- Published by Springer Nature
- p. 49-86
Analytical Strategies and Tactics in Salivary Bioscience
- 8 April 2020
- Published by Springer Nature
- p. 723-746
Public Health and Industry Applications of Salivary Bioscience
- 8 April 2020
- Published by Springer Nature
- p. 723-746
Public Health and Industry Applications of Salivary Bioscience
- 10 September 2019
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 27 (3) , 267-281
Long-Term Associations Between Prenatal Maternal Cortisol and Child Neuroendocrine-Immune Regulation
Background Advancing understanding of the developmental origins of neuroendocrine-immune (NEI) functioning is key to elucidating the biological mechanisms involved in health and disease risk across the lifespan. This study examined whether prenatal maternal hypothalamic-pituitary-adrenal (HPA) activity moderates child NEI relations and explored the consistency of this moderating effect across gestation. Methods Pregnant women participated in five prenatal study visits from 24 to 38 weeks gestation. At each visit, women provided a saliva sample. In a 5-year follow-up study, children (nfemale = 25, nmale=20) provided four saliva samples and participated in behavioral assessments and challenge tasks. Prenatal maternal saliva samples were assayed for cortisol. Child saliva samples were assayed for cortisol and cytokines (IL-1β, IL-6, IL-8, TNFα) as indices of HPA and inflammatory activity. Multilevel mixed-effects models examined the moderation of child NEI relations by prenatal maternal cortisol. Results Among males, average prenatal maternal cortisol did not moderate child NEI relations. Among females, average prenatal maternal cortisol moderated some child NEI relations with higher prenatal cortisol associated with more positive cortisol-cytokine relations at age five. When examined by gestational time point, there were more significant NEI moderation effects by maternal cortisol from later gestation (≥ 30 weeks) than earlier. Conclusions The findings suggest prenatal maternal HPA activity may moderate child NEI functioning. Additional research conducted with more heterogeneous and larger samples is needed to fully understand these relations. Furthering our knowledge of NEI development has important research and clinical implications, particularly for understanding and addressing conditions with inflammatory pathophysiologies, such as depression and cardiovascular disease.
- 10 September 2019
- Published by Springer Nature in International Journal of Behavioral Medicine
- Vol. 27 (3) , 267-281
Long-Term Associations Between Prenatal Maternal Cortisol and Child Neuroendocrine-Immune Regulation
Background Advancing understanding of the developmental origins of neuroendocrine-immune (NEI) functioning is key to elucidating the biological mechanisms involved in health and disease risk across the lifespan. This study examined whether prenatal maternal hypothalamic-pituitary-adrenal (HPA) activity moderates child NEI relations and explored the consistency of this moderating effect across gestation. Methods Pregnant women participated in five prenatal study visits from 24 to 38 weeks gestation. At each visit, women provided a saliva sample. In a 5-year follow-up study, children (nfemale = 25, nmale=20) provided four saliva samples and participated in behavioral assessments and challenge tasks. Prenatal maternal saliva samples were assayed for cortisol. Child saliva samples were assayed for cortisol and cytokines (IL-1β, IL-6, IL-8, TNFα) as indices of HPA and inflammatory activity. Multilevel mixed-effects models examined the moderation of child NEI relations by prenatal maternal cortisol. Results Among males, average prenatal maternal cortisol did not moderate child NEI relations. Among females, average prenatal maternal cortisol moderated some child NEI relations with higher prenatal cortisol associated with more positive cortisol-cytokine relations at age five. When examined by gestational time point, there were more significant NEI moderation effects by maternal cortisol from later gestation (≥ 30 weeks) than earlier. Conclusions The findings suggest prenatal maternal HPA activity may moderate child NEI functioning. Additional research conducted with more heterogeneous and larger samples is needed to fully understand these relations. Furthering our knowledge of NEI development has important research and clinical implications, particularly for understanding and addressing conditions with inflammatory pathophysiologies, such as depression and cardiovascular disease.